文献速递皮肤肿瘤

患者对光化性角化病局部治疗的偏好:一项离散选择实验

Patient preferences for topical treatment of actinic keratoses: a discrete-choice experiment.
PubMed 文献 · Br J Dermatol · 2018-07-26

该离散选择实验作为一项评估局部干预预防皮肤鳞状细胞癌可行性的III期随机对照试验的一部分,调查了109例光化性角化病患者对局部治疗的偏好。多数表达有效偏好的患者愿意接受预防疗效和美容疗效的一定降低,以减少治疗方案负担、皮肤反应严重程度和其他不良反应。患者对治疗效用感知存在显著差异,强调应个体化考虑患者偏好以提高治疗可接受性和依从性。

要点

  • 109例光化性角化病患者完成离散选择实验。
  • 多数表达有效偏好的患者愿意接受预防和美容疗效的降低以减少治疗负担及不良反应。
  • 患者对治疗效用的感知存在显著差异,应个体化考虑偏好。

核心结论

  • 患者对治疗效用的感知存在显著差异,强调应考虑个体患者偏好以提高光化性角化病治疗的可接受性和依从性。

研究设计与样本

  • 离散选择实验作为一项旨在确立采用现有局部干预预防皮肤鳞状细胞癌的III期随机对照试验可行性的研究的一部分。
  • 通过要求患者在具有不同属性水平假设组合的治疗方案之间做出一系列选择来获取偏好。
  • 采用允许患者偏好异质性的灵活选择模型估计治疗属性间的权衡意愿。

主要发现

  • 共109例光化性角化病患者完成离散选择实验。
  • 多数表达有效偏好的患者愿意接受预防疗效和美容疗效的一定降低,以减少治疗方案负担、皮肤反应严重程度和其他不良反应。
  • 如果感知的治疗获益被治疗的主观负担所超过,患者可能拒绝治疗。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The treatment of actinic keratosis (AK) is a potentially effective strategy for the prevention of cutaneous squamous cell carcinoma (cSCC). However, the patient perspective on potential benefits of AK treatment in terms of skin cancer reduction has received little attention to date. OBJECTIVES: (i) To investigate patient preferences for topical treatments for AK using a discrete-choice experiment (DCE); (ii) to evaluate patient willingness to trade between clinical benefit and medical burden. METHODS: The DCE was conducted as part of a study to establish the feasibility of a phase III randomized controlled trial evaluating the prevention of cSCC using currently available topical interventions. Preferences were elicited by asking patients to make a series of choices between treatment alternatives with different hypothetical combinations of attribute levels. Willingness to trade between treatment attributes was estimated using a flexible-choice model that allows for the heterogeneity of patient preferences. RESULTS: A total of 109 patients with AK completed the DCE. The majority of patients who expressed valid preferences were willing to accept some reduction in both prophylactic and cosmetic efficacy to reduce the burden of the treatment regimen, the severity of skin reaction and other adverse effects. Patients may reject treatment if the perceived therapeutic benefit is outweighed by the subjective burden of treatment. CONCLUSIONS: Evidence of significant variation in the perceived utility of treatments across patients highlights the importance of taking individual patient preferences into account to improve AK treatment acceptability and adherence.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Kopasker D, Kwiatkowski A, Matin RN, et al. Patient preferences for topical treatment of actinic keratoses: a discrete-choice experiment. Br J Dermatol. 2018. PMID: 29782648. doi:10.1111/bjd.16801

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。